Frontlight ResearchEarly access
Trial site
Tallahassee Memorial Healthcare
- 11running trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Triple-negative breast cancer3 trials
- Type 1 diabetes2 trials
- Metastatic breast cancer1 trial
- Obesity1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 37 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Active, not recruiting7 trials
- Recruiting4 trials
- Lead sponsor
- Alliance for Clinical Trials in Oncology2 trials
- Eli Lilly and Company2 trials
- NRG Oncology2 trials
- Regeneron Pharmaceuticals2 trials
- H. Lee Moffitt Cancer Center and Research Institute1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 1 diabetes2 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026